Beta-tricalcium phosphate for orthopedic reconstructions as an alternative to autogenous bone graft

Morphologie : Bulletin De L'Association Des Anatomistes
P HernigouC H Flouzat Lachaniette

Abstract

Autogenous bone graft (autograft) remains the gold standard in the treatment of many orthopedic problems. However, graft harvest can lead to perioperative morbidity and increased cost. We tested the hypothesis that an osteoconductive matrix, beta-tricalcium phosphate (β-TCP), would be a safe and effective alternative to autograft alone. Beta-tricalcium phosphate (β-TCP) is considered as one of the most promising biomaterials for bone reconstruction. This study analyzes the outcomes of patients who received β-TCP as bone substitutes in orthopedic surgery. A total of 50 patients were enrolled in a controlled, non-inferiority clinical trial to compare the safety and efficacy of β-TCP (25 patients) with those of autograft (25 patients) in indications requiring usually autograft. These 50 patients were categorized according to the etiology and morphology of the 54 bone defects resulting from elective surgical procedures, such as 34 open-wedge high tibial osteotomies, and 20 osteonecrosis treatments with core decompression. Radiographic (healing process with or without integration of β-TCP), clinical (no other surgical procedure), functional outcomes and safety (with or without complications) were assessed through fifty-two weeks pos...Continue Reading

Citations

Nov 14, 2019·International Journal of Molecular Sciences·Fabio S M YamaguchiRoberta S Stilhano
Apr 8, 2020·Journal of Veterinary Research·Jia-San Zheng Rui-Wu
Jul 20, 2019·Calcified Tissue International·L RonyD Chappard
Mar 10, 2021·Journal of Tissue Engineering and Regenerative Medicine·Hai LiuDaozhang Cai
Mar 9, 2020·Micron : the International Research and Review Journal for Microscopy·Daniel ChappardBernard Guillaume
Aug 16, 2019·Micron : the International Research and Review Journal for Microscopy·Baptiste ArbezDaniel Chappard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.